Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 94, Issue 4, Pages 334-343
Publisher
Springer Nature
Online
2011-10-17
DOI
10.1007/s12185-011-0949-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathogenesis of Myeloma
- (2011) Kenneth C. Anderson et al. Annual Review of Pathology-Mechanisms of Disease
- The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms
- (2011) Methvin Isaac et al. DRUG RESISTANCE UPDATES
- Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients
- (2011) Maurizio Zangari et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma
- (2011) Michel Delforge et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells
- (2011) J Asano et al. LEUKEMIA
- The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts
- (2011) Héctor Peinado et al. SEMINARS IN CANCER BIOLOGY
- A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
- (2010) K. Noonan et al. BLOOD
- A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys
- (2010) Sutada Lotinun et al. BONE
- TGF-β-related mechanisms of bone destruction in multiple myeloma
- (2010) Toshio Matsumoto et al. BONE
- Bone scan images reveal increased osteoblastic function after bortezomib treatment in patients with multiple myeloma
- (2010) Sung-Eun Lee et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro
- (2010) Thomas Lund et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo
- (2010) Andrew D Chantry et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma
- (2010) Xiaoyi Dun et al. Molecular Cancer
- TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
- (2010) Kyoko Takeuchi et al. PLoS One
- Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
- (2010) S. Vallet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
- (2009) Anne Catherine Sprynski et al. BLOOD
- Osteoclasts are important for bone angiogenesis
- (2009) F. C. Cackowski et al. BLOOD
- Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease
- (2009) A. Kukreja et al. BLOOD
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
- (2009) D. W. McMillin et al. CANCER RESEARCH
- 1 Integrin Adhesion Enhances IL-6-Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation
- (2009) K. H. Shain et al. CANCER RESEARCH
- The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts
- (2009) Nadiya M. Teplyuk et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role of the insulin-like growth factor 1 receptor axis in multiple myeloma
- (2009) Eline Menu et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Role of decorin in the antimyeloma effects of osteoblasts
- (2008) X. Li et al. BLOOD
- Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth
- (2008) Y.-W. Qiang et al. BLOOD
- Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
- (2008) Y.-W. Qiang et al. BLOOD
- Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma
- (2008) K. M. Dhodapkar et al. BLOOD
- Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma
- (2008) Martin Kaiser et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4–VCAM-1 adhesion and macrophage inflammatory protein-1α and MIP-1β production
- (2008) Masahiro Abe et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More